Top 100 rádios Podcasts Desporto ao vivo Perto de você Géneros musicais Rádios por tema

Podcasts CiênciaLung Cancer Considered

Ouça este podcast gratuitamente no aplicativo:

radio.net

Sleeptimer

Guardar rádio

Baixe gratuitamente na App Store

Lung Cancer Considered

IASLC

Ciência

Último episódio

383 episódios

IASLC LCC - Early Stage and Preoperative Care for NSCLC and EFGR in Mandarin
20/03/2026 | 48min
In this episode, recorded in Mandarin, host Dr. Chunxia Su leads a discussion about early stage and preoperative care for patients with NSCLC with an EGFR mutation.

Guests:

Wenzhao Zhong, Deputy Prensendent of Guangdong Provincial People's Hospital, Director of the Cancer Institute, Guangdong Provincial People's Hospital

Jie Hu， Deputy director, Department of Respiratory Medicine, Shanghai Geriatric Medical Center，Zhongshan Hospital, Fudan University

Min Fan M D， Deputy Director , Department of Radiation Oncology, Fudan University Shanghai Cancer Center
IASLC - TTLC_Molecular Tumor Board
17/03/2026 | 54min
In this episode of Lung Cancer Considered, host Dr. Narjust Florez conducts three mock molecular tumor boards with Dr. Misako Nagasaka and Dr. Biagio Ricciuti, live from the Targeted Therapies of Lung Cancer (TTLC) 2026 conference. The discussion addresses the question, “How do we get the right molecular answer, at the right time, for the right patient?”

Guests:

Misako Nagasaka, MD, PhD
Associate Clinical Professor
University of California, Irvine

Biagio Ricciuti, MD, PhD
Thoracic Medical Oncologist, Dana-Farber Cancer Institute
Faculty, Harvard School of Medicine
Live from TTLC 2026: ADCs Controversies
10/03/2026 | 38min
In this episode of Lung Cancer Considered, host Dr. Narjust Florez and guest Dr. Sam Rosner examine controversies around antibody-drug conjugates (ADCs) live from the 2026 Targeted Therapies of Lung Cancer (TTLC) conference.

Guest:

Sam Rosner, MD
Assistant Professor of Medicine, University of Maryland School of Medicine
Thoracic Medical Oncologist, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center
LCC in French_Virtual Tumor Board - EFGR NSCLC (1)
06/03/2026 | 43min
As part of IASLC’s ongoing series of podcasts in world languages, Dr. Alfredo Addeo moderates a Virtual Tumor Board discussion with Dr. Angela Botticella and Dr. Jean Yannis Perentes. The tumor board focuses on the management of resectable EGFR-mutant NSCLC.

Guests:

Angela Botticella, MD
Radiational Oncologist
Department of Radiation Oncology
Gustave Roussy

Jean Yannis Perentes, MD, PhD
Professor and Chief, Department of Thoracic Surgery
University Hospital of Lausanne CHUV
Virtual Tumor Board: EGFR-mutant NSCLC
03/03/2026 | 47min
In this episode of Lung Cancer Considered, host Dr. Stephen Liu is joined by Dr. Sara Pilotto and Dr. Jonathan Riess for a virtual tumor board discussion on the management of metastatic EGFR exon 19 NSCLC . Using a complex case featuring discordant biomarker results and brain metastases, the panel explores first-line treatment strategies including osimertinib monotherapy, FLAURA2 (osimertinib plus chemotherapy), and MARIPOSA (amivantamab plus lazertinib), as well as sequencing at progression, re-biopsy, CNS considerations, and the evolving role of local consolidation and clinical trials.

Mais podcasts de Ciência

Podcasts em tendência em Ciência

Sobre Lung Cancer Considered

Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 11,000 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information. Lung Cancer considered is funded in part by Current sponsors: • AbbVie • AstraZeneca • Gilead • J&J • Summit

Site de podcast

Ciência